Form 4: ChromaDex CFO Pamir Ozan Acquires Stock Options
SEC Filing
ChromaDex Corp. CFO Pamir Ozan reported the acquisition of employee stock options on February 12, 2025.
Summary
- Pamir Ozan, the Chief Financial Officer of ChromaDex Corp. (CDXC), filed a Form 4 with the SEC.
- The filing reports a transaction that occurred on February 12, 2025.
- Ozan acquired 17,230 employee stock options with an exercise price of $5.48.
- The options vest in installments, starting February 12, 2026, and expiring on February 11, 2035.
- Following the transaction, Ozan directly owns 17,230 derivative securities (employee stock options).
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding stock option grants, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the compensation and equity ownership of key executives.
Stakeholder Impact
- The granting of stock options aligns the CFO's interests with those of the shareholders, potentially incentivizing performance.
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Date of transaction: Pamir Ozan acquired employee stock options. |
| 02/12/2026 | Vesting start date: One-third of the options begin to vest. |
| 02/11/2035 | Expiration date: Employee stock options expire. |
| 02/14/2025 | Date of filing: Form 4 filing date. |
Keywords
Form 4, ChromaDex, CDXC, stock options, insider trading, Pamir Ozan, CFO, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.